Latest Astellas Pharma Inc. Stories
NEW YORK, April 15, 2014 /PRNewswire-USNewswire/ -- The National Kidney Foundation (NKF) announced today, during National Donate
TOKYO and SAN FRANCISCO, April 3, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503) and Medivation Inc.
TOKYO, March 24, 2014 /PRNewswire/ -- Astellas Pharma Inc.
TOKYO, March 19, 2014 /PRNewswire/ -- Astellas Pharma Inc.
Deeper engagement with Association of Strategic Alliance Professionals reflects pharmaceutical leader’s focus on elevating the practice of alliance management within healthcare industry.
TOKYO, Feb. 28, 2014 /PRNewswire/ -- Astellas Pharma Inc.
-- If isavuconazole is approved for invasive mucormycosis, QIDP status provides a five-year extension of market exclusivity -- NORTHBROOK, Ill., Feb.
In-license Vaccine Technology for Respiratory Syncytial Virus (RSV) from Mymetics TOKYO, ROCKVILLE, Md. and EPALINGES, Switzerland, Jan.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.